Transcode Therapeutics Stock Price History
RNAZ Stock | USD 9.69 0.25 2.52% |
If you're considering investing in Transcode Stock, it is important to understand the factors that can impact its price. As of today, the current price of Transcode Therapeutics stands at 9.69, as last reported on the 22nd of July, with the highest price reaching 9.90 and the lowest price hitting 9.38 during the day. Transcode Therapeutics appears to be moderately volatile, given 3 months investment horizon. Transcode Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0602, which indicates the firm had a 0.0602 % return per unit of risk over the last 3 months. By inspecting Transcode Therapeutics' technical indicators, you can evaluate if the expected return of 0.55% is justified by implied risk. Please review Transcode Therapeutics' Semi Deviation of 7.91, risk adjusted performance of 0.0305, and Coefficient Of Variation of 4330.14 to confirm if our risk estimates are consistent with your expectations.
At this time, Transcode Therapeutics' Common Stock Shares Outstanding is fairly stable compared to the past year. Other Stockholder Equity is likely to rise to about 64.2 M in 2025, despite the fact that Total Stockholder Equity is likely to grow to (1.9 M). . Price Earnings Ratio is likely to drop to -1.47 in 2025. Price Book Value Ratio is likely to drop to -12.24 in 2025. Transcode Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Transcode | Build AI portfolio with Transcode Stock |
Sharpe Ratio = 0.0602
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | RNAZ | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
9.18 actual daily | 82 82% of assets are less volatile |
Expected Return
0.55 actual daily | 11 89% of assets have higher returns |
Risk-Adjusted Return
0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Transcode Therapeutics is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Transcode Therapeutics by adding it to a well-diversified portfolio.
Transcode Therapeutics Stock Price History Chart
There are several ways to analyze Transcode Stock price data. The simplest method is using a basic Transcode candlestick price chart, which shows Transcode Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | May 1, 2025 | 15.79 |
Lowest Price | May 19, 2025 | 6.7 |
Transcode Therapeutics July 22, 2025 Stock Price Synopsis
Various analyses of Transcode Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Transcode Stock. It can be used to describe the percentage change in the price of Transcode Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Transcode Stock.Transcode Therapeutics Price Daily Balance Of Power | (0.48) | |
Transcode Therapeutics Price Action Indicator | (0.08) | |
Transcode Therapeutics Accumulation Distribution | 605.51 | |
Transcode Therapeutics Price Rate Of Daily Change | 0.97 |
Transcode Therapeutics July 22, 2025 Stock Price Analysis
Transcode Stock Price History Data
The price series of Transcode Therapeutics for the period between Wed, Apr 23, 2025 and Tue, Jul 22, 2025 has a statistical range of 9.09 with a coefficient of variation of 21.02. The price distribution for the period has arithmetic mean of 8.72. The median price for the last 90 days is 8.21. The company completed stock split (1:28) on 15th of May 2025.Open | High | Low | Close | Volume | ||
07/21/2025 | 9.64 | 9.90 | 9.38 | 9.69 | 11,528 | |
07/18/2025 | 10.10 | 10.38 | 9.02 | 9.94 | 35,542 | |
07/17/2025 | 9.45 | 10.30 | 9.13 | 10.05 | 33,920 | |
07/16/2025 | 8.91 | 9.44 | 8.78 | 9.38 | 32,245 | |
07/15/2025 | 8.82 | 8.92 | 8.65 | 8.72 | 11,495 | |
07/14/2025 | 8.55 | 9.15 | 8.28 | 9.11 | 14,120 | |
07/11/2025 | 8.91 | 8.91 | 8.50 | 8.69 | 19,888 | |
07/10/2025 | 8.99 | 9.34 | 8.78 | 9.00 | 29,923 | |
07/09/2025 | 9.07 | 9.52 | 9.00 | 9.13 | 27,750 | |
07/08/2025 | 8.10 | 9.70 | 8.04 | 9.25 | 44,677 | |
07/07/2025 | 8.49 | 8.61 | 8.05 | 8.05 | 12,968 | |
07/03/2025 | 8.60 | 8.65 | 8.42 | 8.45 | 13,376 | |
07/02/2025 | 7.75 | 8.35 | 7.74 | 8.29 | 23,133 | |
07/01/2025 | 7.97 | 7.99 | 7.41 | 7.50 | 45,400 | |
06/30/2025 | 7.78 | 8.00 | 7.50 | 7.80 | 12,081 | |
06/27/2025 | 8.21 | 8.40 | 7.81 | 7.97 | 14,750 | |
06/26/2025 | 7.71 | 8.48 | 7.70 | 8.21 | 36,741 | |
06/25/2025 | 7.95 | 7.95 | 7.52 | 7.66 | 7,921 | |
06/24/2025 | 7.32 | 8.45 | 7.32 | 7.79 | 50,086 | |
06/23/2025 | 7.51 | 7.70 | 7.36 | 7.50 | 10,909 | |
06/20/2025 | 7.00 | 7.92 | 6.88 | 7.57 | 60,647 | |
06/18/2025 | 6.94 | 7.08 | 6.80 | 6.98 | 15,350 | |
06/17/2025 | 7.07 | 7.20 | 6.82 | 6.82 | 21,585 | |
06/16/2025 | 6.75 | 7.35 | 6.75 | 7.30 | 30,757 | |
06/13/2025 | 7.10 | 7.62 | 6.80 | 6.97 | 40,301 | |
06/12/2025 | 7.55 | 7.91 | 7.18 | 7.21 | 37,496 | |
06/11/2025 | 7.49 | 7.69 | 7.43 | 7.56 | 16,477 | |
06/10/2025 | 7.52 | 7.62 | 7.27 | 7.37 | 14,256 | |
06/09/2025 | 7.17 | 7.50 | 7.14 | 7.50 | 36,129 | |
06/06/2025 | 7.12 | 7.46 | 7.02 | 7.14 | 33,529 | |
06/05/2025 | 7.23 | 8.18 | 7.07 | 7.22 | 58,723 | |
06/04/2025 | 7.21 | 7.49 | 7.02 | 7.39 | 43,565 | |
06/03/2025 | 6.96 | 7.23 | 6.96 | 7.03 | 23,827 | |
06/02/2025 | 6.80 | 7.36 | 6.80 | 7.09 | 64,252 | |
05/30/2025 | 7.08 | 7.08 | 6.54 | 6.79 | 37,213 | |
05/29/2025 | 7.00 | 7.20 | 6.85 | 6.90 | 50,170 | |
05/28/2025 | 6.87 | 7.46 | 6.85 | 6.97 | 57,914 | |
05/27/2025 | 7.15 | 7.37 | 6.80 | 6.87 | 41,021 | |
05/23/2025 | 7.44 | 7.62 | 6.87 | 6.97 | 64,242 | |
05/22/2025 | 7.99 | 8.06 | 7.30 | 7.62 | 69,380 | |
05/21/2025 | 6.87 | 8.53 | 6.83 | 7.94 | 193,965 | |
05/20/2025 | 6.45 | 7.23 | 6.45 | 7.01 | 159,950 | |
05/19/2025 | 8.03 | 8.28 | 6.15 | 6.70 | 352,512 | |
05/16/2025 | 7.53 | 8.32 | 7.43 | 8.16 | 111,425 | |
05/15/2025 | 8.25 | 8.99 | 7.19 | 7.65 | 176,474 | |
05/14/2025 | 9.72 | 10.07 | 9.36 | 9.71 | 38,920 | |
05/13/2025 | 9.52 | 9.95 | 9.01 | 9.72 | 44,422 | |
05/12/2025 | 9.55 | 10.36 | 9.24 | 10.00 | 63,765 | |
05/09/2025 | 10.08 | 10.08 | 8.96 | 9.57 | 36,883 | |
05/08/2025 | 9.95 | 9.98 | 7.68 | 9.81 | 106,477 | |
05/07/2025 | 10.36 | 10.50 | 9.88 | 9.95 | 54,868 | |
05/06/2025 | 11.45 | 11.48 | 9.86 | 10.14 | 80,253 | |
05/05/2025 | 11.70 | 12.60 | 11.48 | 11.83 | 109,662 | |
05/02/2025 | 15.68 | 15.99 | 13.44 | 14.34 | 301,825 | |
05/01/2025 | 13.39 | 22.03 | 12.98 | 15.79 | 4,654,929 | |
04/30/2025 | 11.90 | 11.90 | 10.82 | 11.38 | 64,699 | |
04/29/2025 | 11.85 | 12.59 | 11.48 | 12.10 | 40,631 | |
04/28/2025 | 10.64 | 12.32 | 10.64 | 11.81 | 114,326 | |
04/25/2025 | 11.45 | 14.01 | 10.64 | 10.64 | 261,055 | |
04/24/2025 | 8.86 | 13.11 | 8.86 | 11.20 | 366,227 | |
04/23/2025 | 9.24 | 9.66 | 8.78 | 8.79 | 72,089 |
About Transcode Therapeutics Stock history
Transcode Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Transcode is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Transcode Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Transcode Therapeutics stock prices may prove useful in developing a viable investing in Transcode Therapeutics
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 356.1 K | 373.9 K | |
Net Loss | -15.8 M | -15 M |
Transcode Therapeutics Stock Technical Analysis
Transcode Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
All Next | Launch Module |
Transcode Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Transcode Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Transcode Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Transcode to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0305 | |||
Jensen Alpha | 0.0055 | |||
Total Risk Alpha | (1.18) | |||
Sortino Ratio | 0.0091 | |||
Treynor Ratio | 0.1396 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Transcode Stock Analysis
When running Transcode Therapeutics' price analysis, check to measure Transcode Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Transcode Therapeutics is operating at the current time. Most of Transcode Therapeutics' value examination focuses on studying past and present price action to predict the probability of Transcode Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Transcode Therapeutics' price. Additionally, you may evaluate how the addition of Transcode Therapeutics to your portfolios can decrease your overall portfolio volatility.